Allen Capital Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.1M | Buy |
169,185
+26,149
| +18% | +$634K | 0.42% | 57 |
|
|
2025
Q1 | $3.62M | Buy |
143,036
+17,454
| +14% | +$442K | 0.41% | 58 |
|
|
2024
Q4 | $3.33M | Buy |
125,582
+11,661
| +10% | +$309K | 0.4% | 54 |
|
|
2024
Q3 | $3.3M | Buy |
113,921
+9,546
| +9% | +$276K | 0.41% | 54 |
|
|
2024
Q2 | $2.92M | Buy |
104,375
+586
| +0.6% | +$16.4K | 0.4% | 57 |
|
|
2024
Q1 | $2.88M | Sell |
103,789
-3,969
| -4% | -$110K | 0.41% | 54 |
|
|
2023
Q4 | $3.1M | Buy |
107,758
+40,145
| +59% | +$1.16M | 0.49% | 44 |
|
|
2023
Q3 | $2.29M | Buy |
67,613
+2,026
| +3% | +$68.8K | 0.41% | 54 |
|
|
2023
Q2 | $2.41M | Buy |
65,587
+4,164
| +7% | +$153K | 0.41% | 54 |
|
|
2023
Q1 | $2.51M | Buy |
+61,423
| New | +$2.51M | 0.46% | 52 |
|
|
2022
Q4 | – | Sell |
-43,825
| Closed | -$1.92M | – | 120 |
|
|
2022
Q3 | $1.92M | Buy |
43,825
+2,086
| +5% | +$91.3K | 0.44% | 50 |
|
|
2022
Q2 | $2.19M | Buy |
41,739
+795
| +2% | +$41.7K | 0.44% | 47 |
|
|
2022
Q1 | $2.12M | Buy |
40,944
+1,351
| +3% | +$70K | 0.4% | 54 |
|
|
2021
Q4 | $2.34M | Buy |
39,593
+172
| +0.4% | +$10.2K | 0.38% | 50 |
|
|
2021
Q3 | $1.7M | Buy |
39,421
+1,064
| +3% | +$45.7K | 0.34% | 62 |
|
|
2021
Q2 | $1.5M | Buy |
38,357
+9,974
| +35% | +$391K | 0.3% | 65 |
|
|
2021
Q1 | $1.03M | Buy |
28,383
+6,424
| +29% | +$233K | 0.23% | 76 |
|
|
2020
Q4 | $808K | Buy |
21,959
+857
| +4% | +$31.5K | 0.19% | 80 |
|
|
2020
Q3 | $739K | Sell |
21,102
-128
| -0.6% | -$4.48K | 0.19% | 79 |
|
|
2020
Q2 | $659K | Buy |
+21,230
| New | +$659K | 0.17% | 78 |
|
|
2019
Q1 | – | Sell |
-10,766
| Closed | -$434K | – | 117 |
|
|
2018
Q4 | $434K | Buy |
10,766
+3,294
| +44% | +$133K | 0.15% | 87 |
|
|
2018
Q3 | $312K | Buy |
7,472
+930
| +14% | +$38.8K | 0.1% | 103 |
|
|
2018
Q2 | $225K | Sell |
6,542
-2,186
| -25% | -$75.2K | 0.08% | 110 |
|
|
2018
Q1 | $294K | Buy |
+8,728
| New | +$294K | 0.11% | 97 |
|